Insulet (Nasdaq:PODD) announced today that the FDA cleared its Omnipod 5 automated insulin delivery for use by people with type 2 diabetes. Clearance makes Omnipod 5, the company’s latest-generation AID system, the first and only such system cleared for type 1 and type 2 diabetes. Its indication covers those ages 18 and older in the type 2 population, while the system has been cleared for ages two and up in the type 1 bracket since 2022.

FDA clears Insulet Omnipod 5 for people with type 2 diabetes

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now available for purchase without a prescription at Stelo.com. Dexcom designed Stelo for adults 18 years and older who are not taking any insulin therapies—a group that includes about 25 million people living with Type 2 diabetes in the U.S. It's also designed to help those with prediabetes reach their A1c goals and potentially slow the progression of diabetes, according to the company. Also, people without diabetes can use the device to better understand the effects of diet and exercise, the company said.

Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market

Type 2 diabetes can now wear a device that will automatically deliver doses of insulin, following an expanded approval by the FDA on Monday. Called the Omnipod 5, it is the first to be approved for adults with type 2 diabetes and can be worn continuously for up to 3 days, working with a continuous glucose monitor.

Automated Insulin Device Now FDA-Approved for Type 2 Diabetes

In this episode, hosts discuss the implications of Dexcom announcing availability of their Stelo sensor and the FDA clearance of the Omnipod 5 for type 2 diabetes. August 26, 2024 will be remembered as the start of a new era in glucose monitoring and management. A day beginning with Dexcom’s announcement of availability and pricing for the first OTC glucose sensor in the Dexcom Stelo and ending with the FDA’s announcement of clearance for the Omnipod 5 Automated Insulin Delivery System (AID) for adults with type 2 diabetes—the first AID to receive FDA clearance for type 1 and type 2 diabetes.

Diabetes Dialogue: Stelo OTC Availability and Omnipod 5 for Type 2 Diabetes

Parade

Find out when tracking your blood sugar can be helpful.

'I'm an Endocrinologist, and These Are the Exact Glucose Numbers to Aim for If You Want to Prevent Diabetes'

Health

Medically reviewed by Isabel Casimiro, MD, PhDMedically reviewed by Isabel Casimiro, MD, PhDBlood sugar is the level of glucose (sugar) in your blood. Keeping blood sugar levels within a normal range—between 70-100 milligrams per deciliter (mg/dL)—helps prevent health conditions like diabetes, a chronic (long-term) condition in which your blood sugar levels are too high. Certain foods and drinks can help you lower your blood sugar to keep it within a healthy range.Prolonged hyperglycemia (high blood sugar) symptoms may include frequent headaches, fatigue, and blurred vision. Lifestyle factors that can improve your blood sugar levels include engaging in physical activity, managing...

4 Drinks That Lower Blood Sugar

Insulin pens have become a game-changer for people managing diabetes. These handy devices offer a convenient, precise way to administer insulin without the hassle of traditional syringes. But what makes them so special? Insulin pens combine ease of use with accuracy, ensuring that users get the right dose every time. They come in various types, including disposable and reusable options, catering to different needs and preferences. With features like dose memory and fine-tuned dosing increments, insulin pens simplify diabetes management. Whether you're new to diabetes care or a seasoned pro, understanding the benefits and functionalities of these pens can make a significant difference in your daily routine.

24 Facts About Insulin Pens

Even if you're not diabetic, being able to monitor your blood sugar level with a good glucose meter is a useful metric to keep tabs on your health. You can use this information to make informed decisions about your diet, exercise, medication and overall lifestyle. The best glucose meter is...

Best Glucose Meter for Diabetes & Blood Sugar Monitoring

Reuters

(Reuters) -All doses of Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are now available, the U.S. Food and Drug Administration's updated shortage list showed on Friday.

US FDA says all doses of Lilly's weight-loss and diabetes drug are now available

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Shin

Statins are widely recognized for their role in lowering low-density lipoprotein (LDL) cholesterol and reducing the risk of heart disease. But new research from the Cholesterol Treatment Trialists’ Collaboration (CTSU) has revealed that these life-saving medications may come with a small but significant drawback—an increased risk of developing diabetes, particularly in individuals already predisposed to the condition.

Statins and Diabetes: New Comprehensive Research Confirms Elevated Risk

Ozempic and Wegovy may have some new competition. Eli Lilly has announced that its new diabetes drug, Zepbound (tirzepatide), reduced the risk of developing Type 2 diabetes by 94% in prediabetic adults in a clinical trial. Additionally, treatment with tirzepatide resulted in sustained weight loss through the treatment period, with...

Eli Lilly says its new diabetes drug was 94% effective in clinical trials

Apple Valley News Now

(CNN) — Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply as it sees continued high demand.

Lilly launches lower-price weight loss drug without injector pen

Medical News Today

New research has found that people taking sulfonylurea, a common drug used for diabetes management, appear to be increasingly desensitized to signs that they are experiencing a hypoglycemic episode.

Common diabetes drug may desensitize people to dangerous drop in blood sugar

Everyday Health

Adults in a preliminary study who had prediabetes and were overweight or had obesity also lost between 15 and 23 percent of their body weight.

Zepbound and Mounjaro Might Completely Erase Your Diabetes Risk

The popular sugar substitute erythritol may increase a person's risk of blood clots, a new study finds.

A popular low calorie sweetener may raise the risk of blood clotting

Type 1 diabetes occurs when the body does not produce enough insulin, the hormone that controls blood glucose (sugar). The condition is less common than type 2 diabetes, which affects around. around the world live with type 1 diabetes. Although the exact cause of this condition is unknown, having a...

Is real-time blood sugar control becoming a reality with smart insulin?

Virginia State

Margaret Minnicks

According to WTKR, Big Lots is closing about 315 of its stores across the United States. An earlier version of this story stated that 42 stores in Virginia would close. However, an updates states that only nine stores in Virginia are closing.

Big Lots will close nine stores in Virginia

WRTV

A three-year study of tirzepatide (Mounjaro/Zepbound) found that when adults who had prediabetes and obesity or overweight used it weekly, it lowered their risk of progression to diabetes by 94%

New diabetes, weight loss medications cut diabetes risk by 94%, Lilly says

BGR.com

We might be closer than ever to curing diabetes. A few promising breakthroughs show it might be possible to repair the pancreas and restore insulin production. There are also behavioral therapies that work, like a liquid 900-calorie diet that can reverse diabetes. However, these developments can only apply to type 2 diabetes for the time being.
There’s also type 1 diabetes, the rarer but slightly more dangerous version. Here, it’s crucial to monitor glucose levels and administer insulin throughout the day to ensure blood sugar stays within optimal levels.
Without insulin, the body won’t break down sugars, which can lead to life-threatening...

Smart insulin could be the closest we get to a cure for type 1 diabetes

A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight used it weekly, it lowered their risk of progression to diabetes by 94% compared with a placebo, according to drugmaker Eli Lilly.

Tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says

NewsBreak

Dexcom Announces Availability, Pricing of Stelo—First OTC Glucose Sensor

Dexcom's Stelo, the first OTC glucose sensor, launches in the US on August 26, 2024, offering 15-day wear and HSA/FSA eligibility for as low as $89.99...

Dexcom Announces Availability, Pricing of Stelo—First OTC Glucose Sensor

Comments / 0